4518
M.P.Y. Yu et al. / Journal of Organometallic Chemistry 691 (2006) 4514–4531
1
Yield: 25%. H NMR (CDCl3): d 7.74–7.22 (20H, PPh2),
7.05 (d, J = 8.6 Hz, 2H, C6H4NC), 6.40 (d, J = 8.6 Hz,
2H, C6H4NC), 3.02–2.87 (m, 2H, CH2PPh2), 2.78–2.64
(m, 2H, CH2PPh2). 13C{1H} NMR (CDCl3): d 260.0
2.16. Synthesis of compound 23
The synthesis follows the procedure described for 20,
using 10 and PdI2. Orange-yellow micro-crystals. Yield:
1
cis
trans
1
1
(W„C), 211.8 (CO, JPC ¼ 7:0 Hz; JPC ¼ 46:0 Hz),
151.4, 135.9, 135.6, 133.0, 132.9, 132.8, 132.6, 132.8,
132.4, 132.3, 132.0, 130.5, 130.4, 130.3, 130.2, 128.9,
128.8, 128.7, 128.6, 128.5, 128.4, 128.0, 125.9, 125.7,
122.6 (PPh2, C6H4NC), 27.5, 27.4, 27.2, 27.1 (CH2PPh2).
31P NMR (CDCl3): d 37.8 (1JWP = 232 Hz). IR (CH2Cl2,
cmꢀ1): 2199 (m, mCN), 2014 (s, mCO), 1946 (s, mCO). mp
150–152 ꢁC (dec.).
30%. H NMR (CDCl3): d 7.75–7.61 (8H, PPh2), 7.59 (d,
J = 6.8 Hz, 2H, C6H4NC), 7.52 (d, J = 6.8 Hz, C6H4NC),
7.50–7.20 (12H, PPh2), 7.11 (d, J = 8.3 Hz, 2H,
C6H4CC), 6.46 (d, J = 8.3 Hz, 2H, C6H4CC), 2.97–2.89
(m, 2H, CH2PPh2), 2.72–2.64 (m, 2H, CH2PPh2).
13C{1H} NMR (CDCl3): d 264.5 (W„C), 212.2 (CO,
cis
trans
1
1JPC ¼ 6:0 Hz; JPC ¼ 46:0 Hz), 149.4, 135.9, 135.3,
133.0, 132.9, 132.8, 132.7, 132.6, 132.5, 132.0, 130.8,
130.3, 130.1, 129.5, 128.6, 128.5, 128.3, 126.8, 124.5,
120.3 (PPh2, C6H4CC, C6H4NC), 94.1, 89.5 (C„C), 27.6,
27.4, 27.2, 27.0 (CH2PPh2). 31P NMR (CDCl3): d 38.5
(1JWP = 231 Hz). IR (CH2Cl2, cmꢀ1): 2201 (m, mCN), 2008
(s, mCO), 1940 (s, mCO). Anal. Calc. for C88H64Cl2I2-
N2O4P4PdW2 Æ 0.5CH2Cl2: C, 48.78; H, 3.01; N, 1.29.
Found: C, 48.67; H, 2.73; N, 1.37%. mp 135–139 ꢁC (dec.).
2.14. Synthesis of compound 21
The synthesis follows the procedure described for 20,
whereby PtI2 was used. The mixture of 9 and PtI2 was stir-
red at r.t. for 2 h to afford 21 as orange microcrystals.
1
Yield: 0.13 g, 72%. H NMR (CDCl3): d 7.74–7.21 (20H,
PPh2), 7.04 (d, J = 8.6 Hz, 2H, C6H4NC), 6.40 (d,
J = 8.6 Hz, 2H, C6H4NC), 3.02–2.86 (m, 2H, CH2PPh2),
2.80–2.62 (m, 2H, CH2PPh2). 13C{1H} NMR (CDCl3): d
2.17. Synthesis of compound 24
cis
trans
260.1 (W„C), 211.8 (CO, 1JPC ¼ 7:0 Hz; JPC
¼ 46:0 Hz), 184.3 (N„C), 151.3, 135.9, 135.6, 134.1,
134.0, 133.0, 132.9, 132.8, 132.6, 132.5, 132.4, 132.3,
132.0, 130.5, 130.4, 130.3, 130.2, 128.8, 128.7, 128.6,
128.5, 128.4, 126.0, 125.9, 122.8 (PPh2, C6H4NC), 27.5,
27.4, 27.3, 27.2 (CH2PPh2). 31P NMR (CDCl3): d 37.8
(1JWP = 232 Hz). IR (CH2Cl2, cmꢀ1): 2191 (m, mCN), 2014
(s, mCO), 1946 (s, mCO). mp 170–172 ꢁC (dec.).
The synthesis follows the procedure described for 21,
using 10 and PtI2. Orange-yellow micro-crystals. Yield:
1
1
30%. H NMR (CDCl3): d 7.74–7.65 (8H, PPh2), 7.58 (d,
J = 8.6 Hz, 2H, C6H4NC), 7.51 (d, J = 8.6 Hz, 2H,
C6H4NC), 7.39–7.20 (12H, PPh2), 7.11 (d, J = 8.3 Hz,
2H, C6H4CC), 6.46 (d, J = 8.3 Hz, 2H, C6H4CC), 3.01–
2.86 (m, 2H, CH2PPh2), 2.74–2.64 (m, 2H, CH2PPh2).
13C{1H} NMR (CDCl3): d 264.4 (W„C), 212.3 (CO,
cis
trans
1
1JPC ¼ 7:0 Hz; JPC ¼ 45:0 Hz), 149.4, 135.8, 135.4,
134.0, 132.9, 132.7, 132.6, 132.5, 132.4, 132.2, 132.0,
131.1, 130.8, 130.5, 130.3, 130.2, 129.5, 129.4, 129.2,
128.8, 128.6, 128.5, 128.4, 128.3, 127.8, 126.9, 126.7,
124.8, 120.4 (PPh2, C6H4NC, C6H4CC), 94.1, 89.6
(C„C), 27.4, 27.3, 27.2, 27.1 (CH2PPh2). 31P NMR
(CDCl3): d 38.5 (1JWP = 231 Hz). IR (CH2Cl2, cmꢀ1):
2197 (m, mCN), 2006 (s, mCO), 1942 (s, mCO). Anal. Calc.
for C88H64Cl2I2N2O4P4PtW2 Æ 0.5CH2Cl2: C, 46.88; H,
2.89; N, 1.24. Found: C, 46.77; H, 2.21; N, 1.45%. mp
147–150 ꢁC (dec.).
2.15. Synthesis of compound 22
ReCl(CO)5 (20 mg) was dissolved in THF (30 mL) and
stirred under reflux overnight. Then 0.118 g (20% excess)
of 10 was added. The resulting mixture was stirred at r.t.
for 4 h. The solvent was removed in vacuo. The residue
was washed with hexane, dried, and redissolved in
CH2Cl2. After filtration, hexane was added to the solu-
tion to afford orange micro-crystals. Yield: 50 mg
1
(43%). H NMR (CDCl3): d 7.72–7.59 (8H, PPh2), 7.56
(d, J = 8.7 Hz, 2H, C6H4NC), 7.47 (d, J = 8.7 Hz, 2H,
C6H4NC), 7.44–7.15 (12H, PPh2), 7.10 (d, J = 8.3 Hz,
2H, C6H4CC), 6.46 (d, J = 8.3 Hz, 2H, C6H4CC), 2.95–
2.88 (m, 2H, CH2PPh2), 2.71–2.59 (m, 2H, CH2PPh2).
13C{1H} NMR (CDCl3): d 264.5 (W„C), 211.9 (CO,
1JcPiCs ¼ 8:0 Hz), 186.3, 183.9 (ReCO), 149.3, 146.6,
135.9, 135.3, 134.1, 133.5, 133.0, 132.9, 132.8, 132.7,
132.5, 132.4, 132.3, 132.0, 131.0, 130.8, 130.7, 130.6,
130.5, 130.3, 130.1, 129.5, 129.2, 128.9, 128.8, 128.6,
128.5, 128.4, 128.3, 127.1, 127.0, 125.6, 120.4 (PPh2,
C6H4NC, C6H4CC), 93.6, 89.7 (C„C), 27.6, 27.4, 27.2,
2.18. Synthesis of compound 25
Compound 11 (290 mg) was added to a suspension of
PdI2 (48 mg) in THF (30 mL). The mixture was stirred at
r.t. overnight, followed by filtration. Then the solvent
was removed in vacuo. The residue was washed with hex-
ane, dried, and redissolved in CH2Cl2. After filtration, hex-
ane was added to the solution to afford a yellow-orange
1
crystalline solid. Yield: 32%. H NMR (CDCl3): d 7.73–
7.67 (8H, PPh2), 7.53 (d, J = 8.4 Hz, 2H, C6H4), 7.49 (d,
J = 8.4 Hz, 2H, C6H4), 7.41–7.21 (14H, PPh2, C6H2i-Pr2),
7.10 (d, J = 8.3 Hz, 2H, CC6H4), 6.46 (d, J = 8.3 Hz, 2H,
CC6H4), 3.59–3.53 (m, 2H, CH(CH3)2), 2.98–2.89 (m,
2H, CH2PPh2), 2.70–2.61 (m, 2H, CH2PPh2), 1.36 (d,
J = 6.8 Hz, 12H, CH3). 13C{1H} NMR (CDCl3): d 264.9
27.0 (CH2PPh2). 31P NMR (CDCl3):
d
39.2
(1JWP = 231 Hz). IR (CH2Cl2, cmꢀ1): 2210 (w, mC„C),
2185 (w, mCN), 2151 (m, mCN), 2039 (s, mRe–CO), 2008 (s,
m
CO), 1994 (s, mRe–CO), 1940 (s, mCO). mp 150–153 ꢁC
(dec.).